Digital repository of Slovenian research organisations

Show document
A+ | A- | Help | SLO | ENG

Title:Zdravljenje razsejanega karcinoma rektuma z imunoterapijo : klinični primer
Authors:ID Drobnič, Alja (Author)
ID Boc, Marko (Author)
ID Volk, Neva (Author)
Files:.pdf PDF - Presentation file, download (91,18 KB)
MD5: 28B9724A596E4FC11EAF1412E5A81F03
 
Language:Slovenian
Typology:1.08 - Published Scientific Conference Contribution
Organization:Logo OI - Institute of Oncology
Abstract:Rak debelega črevesa in danke je med najpogostejšimi raki. Ob postavitvi diagnoze ima 23 % bolnikov razsejano obliko bolezni, 5-letno čisto preživetje bolnikov z razsejano boleznijo je 9 %. Z imunoterapijo lahko pri tumorjih z mutacijami v MMR (mismatch repair) genih oziroma visoko mikrosatelitno nestabilnostjo (MSI-H) dosežemo dolgotrajen odgovor na zdravljenje. V nadaljevanju je predstavljen primer bolnika na zdravljenju s pembrolizumabom, pri katerem smo dosegli regres bolezni.
Keywords:rak rektuma, sistemsko zdravljenje, rak prebavil
Publication status:Published
Publication version:Version of Record
Place of publishing:Ljubljana
Publisher:Onkolološki inštitut
Year of publishing:2022
Number of pages:Str. 46-48
PID:20.500.12556/DiRROS-16051 New window
UDC:616.3
COBISS.SI-ID:135648003 New window
Copyright:by Authors
Note:Nasl. z nasl. zaslona; Opis vira z dne 29. 12. 2022;
Publication date in DiRROS:12.01.2023
Views:1074
Downloads:315
Metadata:XML DC-XML DC-RDF
:
DROBNIČ, Alja, BOC, Marko and VOLK, Neva, 2022, Zdravljenje razsejanega karcinoma rektuma z imunoterapijo : klinični primer. In : Tumorji prebavil [online]. Published Scientific Conference Contribution. Ljubljana : Onkolološki inštitut . 2022. p. 46–48. [Accessed 9 April 2025]. Retrieved from: https://dirros.openscience.si/IzpisGradiva.php?lang=eng&id=16051
Copy citation
  
Share:Bookmark and Share


Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a monograph

Title:Tumorji prebavil : Standardi in perspektive
Editors:Marko Boc, Tanja Mesti
Place of publishing:Ljubljana
Publisher:Onkološki inštitut, Sekcija za internistično onkologijo, Katedra za onkologijo
Year of publishing:2022
ISBN:978-961-7029-55-0
COBISS.SI-ID:133694211 New window

Secondary language

Language:English
Title:Treatment of disseminated rectal carcinoma with immunotherapy : a case report
Abstract:Colorectal cancer is among the most common cancers. At diagnosis, 23% of patients have disseminated form of the disease, the 5-year net survival of patients with disseminated disease is 9%. With immunotherapy in tumors with mutations in MMR (mismatch repair) genes or high microsatellites instability (MSI-H), we can achieve a long-term response to treatment. We present a case report of a patient treated with pembrolizumab, in whom we achieved disease regression.


Back